Literature DB >> 29703792

The APOL1 Long-Term Kidney Transplantation Outcomes Network-APOLLO.

Barry I Freedman1, Marva Moxey-Mims2.   

Abstract

Keywords:  APOL1; African; Apolipoprotein L1; Chronic; Focal Segmental; Genetic; Genetics; Genotype; Glomerulosclerosis; Kidney Failure; Prevalence; Registries; Retrospective Studies; Selection; Tissue Donors; Transplant Recipients; Trypanosomiasis; chronic kidney disease; hypertension; kidney; kidney transplantation; lupus nephritis; quality of life; renal dialysis

Mesh：

Substances：

Year:  2018        PMID： 29703792      PMCID： PMC5989686          DOI： 10.2215/CJN.01510218

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  African American living-kidney donors should be screened for APOL1 risk alleles.

Authors:  David M Cohen; Anuja Mittalhenkle; David L Scott; Carlton J Young; Douglas J Norman
Journal:  Transplantation       Date:  2011-10-15       Impact factor: 4.939

3.  APOL1 Genotype and Renal Function of Black Living Donors.

Authors:  Mona D Doshi; Mariella Ortigosa-Goggins; Amit X Garg; Lihua Li; Emilio D Poggio; Cheryl A Winkler; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2018-01-16       Impact factor: 10.121

4.  Effect of waiting time on renal transplant outcome.

Authors:  H U Meier-Kriesche; F K Port; A O Ojo; S M Rudich; J A Hanson; D M Cibrik; A B Leichtman; B Kaplan
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

5.  Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index.

Authors:  B A Julian; R S Gaston; W M Brown; A M Reeves-Daniel; A K Israni; D P Schladt; S O Pastan; S Mohan; B I Freedman; J Divers
Journal:  Am J Transplant       Date:  2017-01-03       Impact factor: 8.086

6.  Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.

Authors:  K A Newell; R N Formica; J S Gill; J D Schold; J S Allan; S H Covington; A C Wiseman; A Chandraker
Journal:  Am J Transplant       Date:  2017-02-02       Impact factor: 8.086

Review 7.  Clinical Genetic Testing for APOL1: Are we There Yet?

Authors:  Bessie A Young; Stephanie Malia Fullerton; James G Wilson; Kerri Cavanaugh; Erika Blacksher; Clarence Spigner; Jonathan Himmelfarb; Wylie Burke
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

Review 8.  Apolipoprotein L1 Gene Effects on Kidney Transplantation.

Authors:  Barry I Freedman; Jayme E Locke; Amber M Reeves-Daniel; Bruce A Julian
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

9.  New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes.

Authors:  Ajay K Israni; Nicholas Salkowski; Sally Gustafson; Jon J Snyder; John J Friedewald; Richard N Formica; Xinyue Wang; Eugene Shteyn; Wida Cherikh; Darren Stewart; Ciara J Samana; Adrine Chung; Allyson Hart; Bertram L Kasiske
Journal:  J Am Soc Nephrol       Date:  2014-05-15       Impact factor: 10.121

10.  Mid- and Long-Term Health Risks in Living Kidney Donors: A Systematic Review and Meta-analysis.

Authors:  Linda M O'Keeffe; Anna Ramond; Clare Oliver-Williams; Peter Willeit; Ellie Paige; Patrick Trotter; Jonathan Evans; Jonas Wadström; Michael Nicholson; Dave Collett; Emanuele Di Angelantonio
Journal:  Ann Intern Med       Date:  2018-01-30       Impact factor: 25.391
  10 in total
  21 in total

Review 1.  Mechanisms of Injury in APOL1-associated Kidney Disease.

Authors:  Lijun Ma; Jasmin Divers; Barry I Freedman
Journal:  Transplantation       Date:  2019-03       Impact factor: 4.939

Review 2.  Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.

Authors:  Alejandra M Mena-Gutierrez; Amber M Reeves-Daniel; Colleen L Jay; Barry I Freedman
Journal:  Transplantation       Date:  2020-01       Impact factor: 4.939

3.  How the Kidney Health Initiative Catalyzes Innovation in a Dynamic Environment.

Authors:  Raymond C Harris; Zachary Cahill
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-06       Impact factor: 8.237

Review 4.  Ten years in: APOL1 reaches beyond the kidney.

Authors:  Joshua S Waitzman; Jennie Lin
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

Review 5.  APOL1 Genetic Testing in Living Kidney Transplant Donors.

Authors:  Sumit Mohan; Ana S Iltis; Deirdre Sawinski; James M DuBois
Journal:  Am J Kidney Dis       Date:  2019-04-11       Impact factor: 8.860

Review 6.  Lupus nephritis: challenges and progress.

Authors:  Anne Davidson; Cynthia Aranow; Meggan Mackay
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

Review 7.  A focus on the association of Apol1 with kidney disease in children.

Authors:  Pepe M Ekulu; Agathe B Nkoy; Oyindamola C Adebayo; Orly K Kazadi; Michel N Aloni; Fanny O Arcolino; Rene M Ngiyulu; Jean-Lambert E Gini; François B Lepira; Lamberthus P Van den Heuvel; Elena N Levtchenko
Journal:  Pediatr Nephrol       Date:  2020-04-06       Impact factor: 3.714

8.  Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant.

Authors:  Y Dana Neugut; Sumit Mohan; Ali G Gharavi; Krzysztof Kiryluk
Journal:  Ann Intern Med       Date:  2019-10-08       Impact factor: 25.391

Review 9.  APOL1 Nephropathy: From Genetics to Clinical Applications.

Authors:  David J Friedman; Martin R Pollak
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-02       Impact factor: 8.237

Review 10.  Risk Factors for CKD Progression: Overview of Findings from the CRIC Study.

Authors:  Mary Hannan; Sajid Ansari; Natalie Meza; Amanda H Anderson; Anand Srivastava; Sushrut Waikar; Jeanne Charleston; Matthew R Weir; Jonathan Taliercio; Edward Horwitz; Milda R Saunders; Katherine Wolfrum; Harold I Feldman; James P Lash; Ana C Ricardo
Journal:  Clin J Am Soc Nephrol       Date:  2020-11-11       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.